fritzideyaniraNorton Medical and Scientific Research & Biotechnology
Posted by fritzideyanira (norton-scientificmedical.com) 67 days ago under norton scientific tools norton medical and scientific research
Norton Medical and Scientific Research & Biotechnology - FDA approves kidney cancer drug from Pfizer
BY ADMIN, 3 MONTHS AND 9 DAYS AGO The medicine made by Pfizer against advanced kidney cancer was recently approved by Norton Medical and Scientific Research & Biotechnology regulators for commercial use despite a warning of possible side effects. On Friday, the Food and Drug Administration (FDA) stated that the drug (with the generic name of axitinib) is effective in curing patients who do not show response to other drugs against kidney cancer. The advance stage of kidney cancer usually begins in the lining of the kidney's tubes. Inlyta does its work by blocking specific receptors that are involved in the growth of tumor. According to FDA, Inlyta is already the seventh drug it approved to cure advanced cancer of the kidney since 2005. American Cancer Society said that more than 60,000 Americans are diagnosed with kidney cancer last year and 1 out of 5 is expected to die from them. The FDA approval has come as a welcome opportunity for Pfizer since they have lost revenue from their cholesterol drug, Lipitor, after generic counterparts started to come out last year. However, Inlyta will still face tough competition from the 6 other drugs for kidney cancer that have their respective market shares already. An advisory committee of FDA endorsed the oral drug last month and announced that it is as effective and as safe as ... Norton Scientific by Brad Kepler
Posted by fritzideyanira (bradkepler.blog.fc2.com) 88 days ago under norton review invisible man scientific norton scientific by brad kepler
Cancer society decries drug shortage
29March 2012 (NortonScientificCollection) - It is unacceptable that some cancer patients can’t readily get the drugs they need because of supply problems, the Canadian Cancer Society says. The society is hearing from worried patients and doctors across the country, said Dan Demers, the group's director of public issues. "We shouldn't have to wait for a crisis to respond," said Demers. The cancer society urged the federal government to: Ensure there is mandatory listing of unavailable drugs by drug manufacturer. Develop early warning systems to identify potential drug shortages. Put systems in place to prevent shortages from escalating. Work with other jurisdictions to investigate the root causes of the shortages and act to prevent them where possible. Canada's supply of injectable drugs such as painkillers, antibiotics and anesthetics became more precarious following a fire in the boiler room at Sandoz Canada's plant in Boucherville, Que. "Production has resumed in the portion of the plant that was not directly affected by the incident, which took place on March 4," the company said in a email to CBC News on Monday. "Our objective is to restore previous levels of supply as soon as possible, and we will make every effort to meet medical needs, while ensuring consistent high quality standards." Rationing supplies The company was unable to quantify ... « previous next » |
- Login
- Register
- Write a New Post
|
|